Pellett: Virology - Pathogenesis Flashcards

1
Q

Viruses

Result of infection:

Relationship between viruses and disease

3 other principles of viral infections

A

Most result in asymptomatic (subclinical) infections

Same disease may be caused by a variety of different viruses

Same virus may cause a variety of diseases

  • Local vs. systemic infections
  • Seasonality
  • Various incubation periods: time to disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Outcome of infection determined by the interaction of the virus and the host

A
o	Virus strain
o	Route of infection
o	Infectious dose
o	Host immune status
o	Host genetics
o	Virus cytotoxicity
o	Immunopathology
o	Host health
o	Co-infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Routes of Person-to-person transmission (7):

A
Person-to-person transmission: some paths more likely if illness present; others if relatively healthy
	Fecal-oral
	Respiratory
	Animal bite
	Arthropods
	Sexual
	Bloodborne
	Vertically (transplacental, genetic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Incubation periods of:

Influenza
Common cold
Herpes
Rabies
AIDS
A
Influenza: 1-2 days
Common cold: 1-3 days
Herpes: 5-8 days
Rabies: 30- 100 days
AIDS: 1-10 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Latent State:

Cellular:
Organismal:

A

Cellular: no infectious particles produced; can be reactivated to lytic state

Organismal: period between infection and disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Persistent Infection:

Cellular:
Organismal:

A

Cellular: lytic state, equilibrium between cell death and production (but still making virus paticles)

Organismal: continuous inhabitation of the host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Abortive Infection:

A

Abortive Infection: non-productive, not reactivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Patterns of Viral Infection:

o Acute:
o Latent:
o Progressive:
o Chronic or Persistent:

A

o Acute: GI viruses
o Latent: HSV (reactivations occur)
o Progressive: HIV or hep C
o Chronic or Persistent: HIV or hep C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Patterns of Viral Infection:

o Failure to clear all evidence of infection:
o Subclinical/asymptomatic:
o Slow:

A

o Failure to clear all evidence of infection: polio and measles
o Subclinical/asymptomatic: ~50% of HSV transmission is during asymptomatic periods
o Slow: long-term persistence prior to onset of disease (HPV and cervical cancer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Genes groups based on contribution to virulence:

Basic Replication Functions:

Immunevasion:

Cell and tissue tropism:

Toxic products:

A

Genes groups based on contribution to virulence:

Basic Replication Functions: viral RNA polymerase

Immunevasion: proteins that downregulate Ag presentation

Cell and tissue tropism: HIV uses CD4 as cellular receptor

Toxic products: rotavirus NSP4 induces diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Disease in immunocompromised infections (2):

A

Opportunistic infections (OI)

De novo vs. prior infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why does viral load matter?

A

The larger the load, the higher the probability of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Viruses and Cancer: generally unintended by-products of niche-management by the virus

HPV:

HTLV-1:

HHV-8:

EBV:

Hep B/Hep C:

A

Viruses and Cancer: generally unintended by-products of niche-management by the virus

HPV and cervical cancer

HTLV-1 and T cell leukemia

HHV-8 and Kaposi’s sarcoma

EBV and Burkitt’s Lymphoma and nasopharyngeal carcinoma

Hep B/Hep C and liver cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Innate immunity (3):

A

Physical barriers: skin, mucosa, respiratory filters

Intracellular defenses: IFN (and other cytokines), PKR, RNase, stress responses, cell-death (apoptosis, necrosis, autophagy)

NK cells, macrophages and neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acquired immunity (2):

Effect of abs against virions:
Effect of abs against viral proteins on cell surfaces:

A

Antibodies and complement

  • Abs against virions: neutralization
  • Abs against viral proteins on cell surfaces: neutralization, inhibition of viral replication, inhibition of virus release, infected cell lysis and clearance, inhibition of cell-cell transmission

T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Viral immune escape

A

ESSENTIALLY EVERY DEFENSE CAN BE BLOCKED OR CIRCUMVENTED BY A VIRUS

17
Q

Manipulation of the immune system:

What type of virus?
Large DNA viruses:
What are host-derived?

A
  • All viruses do it
  • Large DNA viruses dedicate more genes to the task
  • Many viral immunomodulatory genes are host-derived
18
Q

Targets for immune evasion:

Innate vs. Adaptive Responses

A

Innate Defenses:

  • Apoptosis
  • IFN responses
  • PKR pathway (proten kinase RNA-activated pathway)

Adaptive Responses:
- Ag prensetation

19
Q

What is the PKR pathway?
Activated by:
Net result:
What can the virus do?

A

PKR pathway (proten kinase RNA-activated pathway):

Activated by dsRNA, which is uncommon outside of a virus infection and net result is translational arrest (under normal conditions); the virus can employ mechanisms to inhibit this pathway (allowing translation to occur)

20
Q

Diagnostic tests that detect the agent (5):

A
o	Cytology
o	Electron microscopy
o	Direct fluorescent Ab (DFA)
o	Cell culture
o	Nucleic Acids (PCR)
21
Q

Diagnostic tests that Detect Response to the Agent:

A

Serotology (look for Abs against the agent)

22
Q

What must antivirals do?

A

Must selectively inhibit viral functions without damaging the host

23
Q

Targets of antivirals (5):

A

Targets: every step in replication cycle is potential target

Attachment and entry (fusion inhibitors)

Uncoating (ion channel blockers)

Genome replication (polymerase inhibitors)

Protein synthesis/assembly and maturation (protease inhibitors)

Egress and release (neuraminidase inhibitors)

24
Q

Examples:

Fusion inhibitors:

Ion channel blockers:

Polymerase inhibitors:

Protease inhibitors:

Neuraminidase inhibitors:

A

Fusion inhibitors: Enfuvirtide (T-20)

Ion channel blockers: Amantadine, Rimantadine

Polymerase inhibitors: Acyclovir, Zidovudine, Efavirenz

Protease inhibitors: Saquinavir, Ritonavir

Neuraminidase inhibitors: Zanamivir

25
Why are antivirals relatively ineffective clinically as compared to bacterial agents?
Many rounds of viral replication has occurred during the incubation period before symptoms develop
26
What is most important to prevent infection
vaccination
27
How is acyclovir activated?
Acyclovir must be phosphorylated by viral thymidine kinase
28
Key Issues (5):
``` o Specificity o Toxicity o Rapid diagnosis o Therapeutic threshold o Resistance ```